Cutia Therapeutics (HKG:2487)

Cutia Therapeutics Statistics

Total Valuation

HKG:2487 has a market cap or net worth of HKD 3.01 billion. The enterprise value is 2.58 billion.

Market Cap	3.01B
Enterprise Value	2.58B

Important Dates

The next estimated earnings date is Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:2487 has 348.37 million shares outstanding. The number of shares has increased by 2.95% in one year.

Current Share Class	348.37M
Shares Outstanding	348.37M
Shares Change (YoY)	+2.95%
Shares Change (QoQ)	+2.95%
Owned by Insiders (%)	4.33%
Owned by Institutions (%)	4.71%
Float	82.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.97
PB Ratio	3.63
P/TBV Ratio	3.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.99
EV / Sales	9.41
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.04

Financial Position

The company has a current ratio of 3.16, with a Debt / Equity ratio of 0.38.

Current Ratio	3.16
Quick Ratio	2.77
Debt / Equity	0.38
Debt / EBITDA	n/a
Debt / FCF	-0.74
Interest Coverage	-41.20

Financial Efficiency

Return on equity (ROE) is -48.56% and return on invested capital (ROIC) is -22.59%.

Return on Equity (ROE)	-48.56%
Return on Assets (ROA)	-21.52%
Return on Invested Capital (ROIC)	-22.59%
Return on Capital Employed (ROCE)	-52.75%
Revenue Per Employee	920,492
Profits Per Employee	-1.74M
Employee Count	333
Asset Turnover	0.19
Inventory Turnover	1.96

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.23% in the last 52 weeks. The beta is 0.98, so HKG:2487's price volatility has been similar to the market average.

Beta (5Y)	0.98
52-Week Price Change	-35.23%
50-Day Moving Average	9.48
200-Day Moving Average	7.56
Relative Strength Index (RSI)	37.91
Average Volume (20 Days)	446,425

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2487 had revenue of HKD 274.31 million and -517.51 million in losses. Loss per share was -1.65.

Revenue	274.31M
Gross Profit	137.18M
Operating Income	-494.95M
Pretax Income	-517.51M
Net Income	-517.51M
EBITDA	-461.78M
EBIT	-494.95M
Loss Per Share	-1.65

Balance Sheet

The company has 746.79 million in cash and 318.22 million in debt, giving a net cash position of 428.57 million or 1.23 per share.

Cash & Cash Equivalents	746.79M
Total Debt	318.22M
Net Cash	428.57M
Net Cash Per Share	1.23
Equity (Book Value)	829.09M
Book Value Per Share	2.60
Working Capital	616.40M

Cash Flow

In the last 12 months, operating cash flow was -403.82 million and capital expenditures -23.40 million, giving a free cash flow of -427.23 million.

Operating Cash Flow	-403.82M
Capital Expenditures	-23.40M
Free Cash Flow	-427.23M
FCF Per Share	-1.23

Margins

Gross margin is 50.01%, with operating and profit margins of -180.44% and -188.66%.

Gross Margin	50.01%
Operating Margin	-180.44%
Pretax Margin	-188.66%
Profit Margin	-188.66%
EBITDA Margin	-168.34%
EBIT Margin	-180.44%
FCF Margin	n/a

Dividends & Yields

HKG:2487 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.95%
Shareholder Yield	n/a
Earnings Yield	-17.19%
FCF Yield	-14.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2487 has an Altman Z-Score of -1.09 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.09
Piotroski F-Score	3